Exempt, expedited or full board: which Capella IRB review path is your study on?
Capella's IRB Office assigns the review path, not the researcher, and it does so under the Common Rule: a study is exempt if it fits a category in 45 CFR 46.104 (typically surveys, interviews or educational tests where identities cannot readily be ascertained, or secondary use of de-identified records); it is eligible for expedited review if it is no more than minimal risk and on the OHRP list (where most interview, survey, focus-group and program-evaluation studies sit); and it goes to the full committee when risk is more than minimal, when deception or sensitive topics are involved, or when participants belong to a protected population. Three questions usually settle it: can participants be identified, are any of them vulnerable, and is the risk more than everyday life.
Capella's IRB Office sets the path under 45 CFR 46. Exempt fits a 46.104 category (anonymous surveys, de-identified records); expedited is minimal risk on the OHRP list (most interviews and surveys); full board handles more-than-minimal risk, deception, or vulnerable populations. Identifiers, population and risk decide.
Who decides the review path at Capella?
The IRB, at screening. Capella's Research Integrity SOPs state that the IRB Office screens all studies for the required documents and determines the level of review under the Common Rule and OHRP guidance. Capella's IRB process interactive describes the next step: a school-affiliated reviewer determines whether the research is eligible for expedited review, and studies that are not eligible go to the full IRB committee. The researcher's own view of the path is an input, not a decision; the application asks about population, procedures and identifiers so the office can classify the study. And Capella reviews exempt studies too: the SOPs say the university reviews studies determined exempt to ensure best practice, so "exempt" at Capella means a lighter review, not no review.
Doctoral capstone and DNP projects usually enter through a screening form, and many end in a determination of Not Human Subjects Research rather than any of the three paths; for those, start with Does a Capella DNP project need IRB approval? QI vs research, honestly. This article is about studies that are human subjects research.
What makes a study exempt under 45 CFR 46.104?
The regulation lists eight exempt categories. Four describe most Capella-type studies:
- (d)(1), normal educational practices in established educational settings, not likely to adversely affect learning or the assessment of educators.
- (d)(2), educational tests, surveys, interviews or observation of public behavior, when one of three conditions holds: (i) identity cannot readily be ascertained, directly or through linked identifiers; (ii) any disclosure would not reasonably place the subject at risk of criminal or civil liability or damage their financial standing, employability, educational advancement or reputation; or (iii) identities can be ascertained but an IRB conducts a limited review of privacy and confidentiality under 46.111(a)(7).
- (d)(3), benign behavioral interventions with adults who prospectively agree: brief, harmless, painless, not physically invasive, not likely to have a lasting adverse impact, with the same identifiability or disclosure conditions.
- (d)(4), secondary research on identifiable private information where the information is publicly available, or is recorded so the investigator cannot readily ascertain identity and will not contact or re-identify subjects, or is health information regulated under HIPAA.
Two limits matter at Capella. Under 46.104(b), the exemptions do not apply to research with prisoners (subpart C) except where prisoners are only incidentally included; for children (subpart D), exemption (d)(2) covers only educational tests or public observation in which the investigator does not participate, and (d)(2)(iii) cannot be used. A survey of minors, or interviews in a correctional setting, is not exempt however anonymous.
What makes a study eligible for expedited review?
Two conditions, both from 45 CFR 46.110. The study must involve no more than minimal risk, which 46.102(j) defines as harm or discomfort not greater than that ordinarily encountered in daily life or routine physical or psychological examinations, and it must appear on the list of categories HHS has published in the Federal Register. Expedited review is carried out by the IRB chair or experienced reviewers the chair designates; they may exercise all the authorities of the IRB except that they may not disapprove the research, so a study a reviewer will not approve goes to the convened board.
Three OHRP categories carry most Capella studies:
- Category 5: materials (data, documents, records, specimens) collected, or to be collected, solely for non-research purposes such as medical treatment or diagnosis.
- Category 6: data from voice, video, digital or image recordings made for research purposes.
- Category 7: research on individual or group characteristics or behavior, or research employing survey, interview, oral history, focus group, program evaluation, human factors evaluation or quality assurance methodologies.
The list also carries a warning about identifiers. Its applicability note (C) says the expedited procedure may not be used where identification of the subjects or their responses would reasonably place them at risk of criminal or civil liability or damage their financial standing, employability, insurability or reputation, or be stigmatizing, unless reasonable and appropriate protections make the privacy and confidentiality risks no greater than minimal. An identifiable interview study about workplace misconduct is expedited only if the data security plan genuinely brings that risk down.
When does a study go to the full board?
When it fails the minimal-risk test or when the population or design calls for the convened committee. Capella's IRB interactive lists the triggers: studies involving prisoners; pregnant women, fetuses or neonates; cognitively impaired persons; or institutionalized persons, and studies involving sensitive topics, deception, or greater than minimal risk of harm. The SOPs add that permitted prisoner research is approved only through the full committee.
Some studies cannot be approved at Capella on any path. The SOPs and Policy 3.03.01 list research requiring FDA oversight or investigational drugs or devices, research with human fetuses or neonates, certain categories of prisoner research, and research involving greater than minimal risk to minors or adults under guardianship. A design that depends on any of these is a problem to solve before SMR, not a path to choose.
Which path is your study on? The table the board is effectively using
| Path | Typical Capella study | Identifiers and population | Risk | What the file must show |
|---|---|---|---|---|
| Exempt (46.104) | Anonymous online survey of adult professionals; analysis of de-identified records; normal educational practice in a classroom | Identity not readily ascertainable, or disclosure could not harm; adults (limits for children and prisoners) | Minimal | Category claimed and why; how anonymity or de-identification is achieved; data source and permission; consent information suited to the category |
| Expedited (46.110) | Recorded interviews or focus groups with adults; identifiable survey with a confidentiality plan; program evaluation; analysis of treatment records | Identifiable but protected; no protected population targeted | No more than minimal after protections | OHRP category; full consent on Capella's template; recruitment materials; instruments and permissions; site letters; a data security plan equal to the identifiability |
| Full board | Permitted prisoner research; institutionalized or cognitively impaired adults; sensitive-topic or deception designs; anything above minimal risk | Vulnerable population, or identifiable and high-stakes | More than minimal, or sensitive enough that the committee must weigh it | All of the above, plus 46.111(b) safeguards, a risk/benefit justification, distress and referral procedures, and for prisoners the subpart C findings |
The three questions that usually settle the path
- Can a participant be identified from what you collect or keep? Names, follow-up emails, recordings, small units where a role identifies a person, and linked codes all count. No readily ascertainable identity points toward exempt; identifiable but protected toward expedited; identifiable and high-stakes toward the board.
- Is anyone in the population a protected or vulnerable person? 45 CFR 46.111(a)(3) names children, prisoners, individuals with impaired decision-making capacity, and economically or educationally disadvantaged persons; Capella's guidance adds people who report directly to the researcher, people in acute illness, and others susceptible to undue influence. Targeting any of them moves the path upward or, for some, off the table.
- Is the risk more than everyday life? Not just physical risk: the OHRP list names liability, financial standing, employability, insurability, reputation and stigma. If a breach would cost someone a job or a licence, the data security plan must make that risk minimal, or the study is not expedited.
What does each path need in the file?
The same packet, read at different depths. Every path needs the CITI completion report, the SMR-approved plan, the application, site permission and instruments with permissions; the weight falls differently on consent and data security. For an exempt survey the board wants to see how anonymity is actually achieved: no IP capture, no free-text prompts that elicit names. For an expedited interview study it wants the full consent under 45 CFR 46.116, with its concise key-information opening and basic elements, a recording statement, and a storage, access and destruction plan. For a full-board study it wants the 46.111(b) safeguards and a written account of why the risks are reasonable in relation to the benefits. The document list is in The Capella IRB application checklist; where path assignment sits among the four gates is in Capella IRB process, step by step.
Can the path change once the file is in?
Yes, in both directions. A designated reviewer who finds more than minimal risk refers the study to the full committee, at initial or continuing review. Modifications are reviewed at the level their changes require, so adding a vulnerable population or a recording to an expedited study can move it. Studies first reviewed by the full board may later be reviewed through expedited procedures for continuing review under OHRP categories 8 and 9. None of that is a reason to guess low: a study filed as exempt that is plainly expedited comes back, and the return costs a round trip a correct first filing would not have.
What to do next
If you are not sure which path your study is on, start with the free application review at the contact page. We read your approved plan against 45 CFR 46.104, the OHRP list and Capella's posted criteria and tell you, in writing, the path the design supports and what the file must show. Then we handle the entire IRB process end to end: the determination, every document, the submission through your mentor, and every reply to the board until approval. The study stays yours; the board's decision is its own. See how it works and the FAQ.
Sources
- 45 CFR 46.102, Definitions: law.cornell.edu/cfr/text/45/46.102
- 45 CFR 46.104, Exempt research: law.cornell.edu/cfr/text/45/46.104
- 45 CFR 46.110, Expedited review: law.cornell.edu/cfr/text/45/46.110
- 45 CFR 46.111, Criteria for IRB approval: law.cornell.edu/cfr/text/45/46.111
- 45 CFR 46.116, Informed consent: law.cornell.edu/cfr/text/45/46.116
- OHRP, Expedited review categories (63 FR 60364): govinfo.gov/content/pkg/FR-1998-11-09/html/98-29749.htm
- Capella, Research Integrity SOPs: capella.edu/assets/pdf/policies/HRPP-SOPs.pdf
- Capella Policy 3.03.01, Human Research Protections: capella.edu/content/dam/capella/PDF/policies/3.03.01.pdf
- Capella, IRB process interactive transcript: capella.edu/interactivemedia/IRBprocess/irb_ts.html
- Capella IRB, What is "Not Human Subjects Research?": assets.capella.edu/campus/doctoral-programs/IRB-Information-NHSR-Projects.pdf